These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 37438966)
1. Evaluation of bladder filling effects on the dose distribution during radiotherapy for cervical cancer based on daily CT images. Zhang F; Zhou M; Wang G; Li X; Yue L; Deng L; Chi K; Chen K; Qi Z; Deng X; Peng Y; Liu Y J Appl Clin Med Phys; 2023 Nov; 24(11):e14097. PubMed ID: 37438966 [TBL] [Abstract][Full Text] [Related]
2. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. Bondar ML; Hoogeman MS; Mens JW; Quint S; Ahmad R; Dhawtal G; Heijmen BJ Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1617-23. PubMed ID: 22270164 [TBL] [Abstract][Full Text] [Related]
3. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer. Eminowicz G; Rompokos V; Stacey C; Hall L; McCormack M Radiother Oncol; 2017 Jan; 122(1):116-121. PubMed ID: 27863962 [TBL] [Abstract][Full Text] [Related]
4. Dosimetric impact of variable bladder filling on IMRT planning for locally advanced carcinoma cervix. Dutta S; Dewan A; Mitra S; Sharma MK; Aggarwal S; Barik S; Mahammood Suhail M; Bhushan M; Sharma A; Wahi IK; Dobriyal K; Mukhee J J Egypt Natl Canc Inst; 2020 Jul; 32(1):31. PubMed ID: 32734431 [TBL] [Abstract][Full Text] [Related]
5. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters. Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676 [TBL] [Abstract][Full Text] [Related]
6. CBCT-guided evolutive library for cervical adaptive IMRT. Rigaud B; Simon A; Gobeli M; Lafond C; Leseur J; Barateau A; Jaksic N; Castelli J; Williaume D; Haigron P; De Crevoisier R Med Phys; 2018 Apr; 45(4):1379-1390. PubMed ID: 29453893 [TBL] [Abstract][Full Text] [Related]
7. The impact of daily bladder filling on small bowel dose for intensity modulated radiation therapy for cervical cancer. Chen VE; Gillespie EF; Manger RP; Skerritt LA; Tran JH; Proudfoot JA; Sherer MV; Einck JP; Mell LK; Moore KL; Yashar CM Med Dosim; 2019 Summer; 44(2):102-106. PubMed ID: 29573921 [TBL] [Abstract][Full Text] [Related]
8. A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: a dosimetric evaluation. Ahmad R; Bondar L; Voet P; Mens JW; Quint S; Dhawtal G; Heijmen B; Hoogeman M Acta Oncol; 2013 Oct; 52(7):1430-6. PubMed ID: 23902275 [TBL] [Abstract][Full Text] [Related]
9. Dosimetric impact of bladder volume on organs at risk during external beam radiotherapy of cervical cancer. Mohamadian N; Nasseri S; Hosseini S; Molaie F; Zarifi S; Eskandari A; Momennezhad M Radiat Prot Dosimetry; 2023 Aug; 199(13):1351-1356. PubMed ID: 37366148 [TBL] [Abstract][Full Text] [Related]
10. Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation. Peng H; Zhang J; Xu N; Zhou Y; Tan H; Ren T BMC Cancer; 2023 Jun; 23(1):588. PubMed ID: 37365516 [TBL] [Abstract][Full Text] [Related]
11. Adaptive radiotherapy for muscle invasive bladder cancer: a retrospective audit of two bladder filling protocols. Guel DNB; Laverick N; MacLaren L; MacLeod N; Glegg M; Lamb G; Houston P; Carruthers R; Grocutt L; Valentine RM Radiat Oncol; 2024 Jul; 19(1):92. PubMed ID: 39030548 [TBL] [Abstract][Full Text] [Related]
12. Interfractional dose variation during intensity-modulated radiation therapy for cervical cancer assessed by weekly CT evaluation. Han Y; Shin EH; Huh SJ; Lee JE; Park W Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):617-23. PubMed ID: 16690443 [TBL] [Abstract][Full Text] [Related]
13. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk. Hung J; Shen S; De Los Santos JF; Kim RY Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458 [TBL] [Abstract][Full Text] [Related]
14. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Cozzi L; Dinshaw KA; Shrivastava SK; Mahantshetty U; Engineer R; Deshpande DD; Jamema SV; Vanetti E; Clivio A; Nicolini G; Fogliata A Radiother Oncol; 2008 Nov; 89(2):180-91. PubMed ID: 18692929 [TBL] [Abstract][Full Text] [Related]
15. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT. Heijkoop ST; Langerak TR; Quint S; Bondar L; Mens JW; Heijmen BJ; Hoogeman MS Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):673-9. PubMed ID: 25151538 [TBL] [Abstract][Full Text] [Related]
16. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer. Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467 [No Abstract] [Full Text] [Related]
17. Dosimetric advantages of a clinical daily adaptive plan selection strategy compared with a non-adaptive strategy in cervical cancer radiation therapy. van de Schoot AJAJ; de Boer P; Visser J; Stalpers LJA; Rasch CRN; Bel A Acta Oncol; 2017 May; 56(5):667-674. PubMed ID: 28447562 [TBL] [Abstract][Full Text] [Related]
18. Pelvic Organ Motion during Radiotherapy for Cervical Cancer: Understanding Patterns and Recommended Patient Preparation. Eminowicz G; Motlib J; Khan S; Perna C; McCormack M Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e85-91. PubMed ID: 27178706 [TBL] [Abstract][Full Text] [Related]
20. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]